skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Voted as one of the top 10 countries in INSEAD’s Global Innovation Index 2015, Singapore is keen to nurture its local medtech talent to become world-class, commercial-focused innovators. And the Singapore-Stanford Biodesign program, now in its sixth year, aims to do just that. In this article, the current head of this innovation-training initiative, Ruey Feng Peh, talks about methodology, successes and future plans for the program.

Download now